Business ❯ Healthcare

Drug Development

Clinical Trials Market Competition Eli Lilly FDA Approvals New Products Market Performance Sales Milestones Cancer Treatment Collaboration Patent Issues Immunotherapy Acquisitions Pharmaceuticals Clinical Research Biosimulation Generic Drugs Incretin Medications Innovative Drugs Biosimilars Selinexor Therapeutics Artificial Intelligence Genetic Conditions

Axsome Reports 57% Q1 Sales Jump as FDA Clears Auvelity for Alzheimer’s Agitation

Profit lags as Axsome prioritizes launch spend plus R&D.

Simulations Plus Beats Q2, Lowers FY2026 Profit Outlook

Karyopharm Raises $30 Million in RA Capital Private Placement

AbbVie Beats Q4 and Raises 2026 Outlook as Shares Fall on Aesthetics, Oncology Concerns

Novo’s Wegovy Pill Posts Quick Uptake, Boosting Shares as Oral GLP‑1 Battle Nears

Crinetics Wins FDA Approval for Oral Acromegaly Drug Palsonify as JMP Lifts Price Target

BMO Raises AbbVie Target to $240 After Rinvoq Generic Dispute Is Resolved

Novo Nordisk Freezes Hiring as Layoffs Loom in GLP-1 Retrenchment